18. December 2019

GSK Stockmann advises Everest on the sale of the office complex “Sonnenhöfe“, near Munich

The Frankfurt-based company Everest Management GmbH has sold the Sonnenhöfe (“Sun Courtyards”) office complex near Munich to the investment manager Investcorp from Bahrain. GSK Stockmann provided legal advice to Everest on the sale, which was carried out on behalf of the US-based real estate investor Westport Capital Partners.

The office complex, which was constructed between 1992 and 1994, is located on Inselkammerstraße in Unterhaching, a suburb of Munich. It is a part of the “Sonnenhöfe” Quarter and boasts approximately 30,000 m2 of office space distributed among four buildings.

In addition to the office buildings, the “Sonnenhöfe” Quarter also features a Holiday Inn hotel. Assisted by Everest, the seller Westport Capital Partners purchased the Quarter in 2016 and then proceeded to divide and revitalize it. Since the purchase, GSK Stockmann has comprehensively advised Everest on the development of the Quarter regarding all property-related, real estate and public law issues. GSK Stockmann prepared the sale of the office complex with an extensive Legal Fact Book.

Advisers of Everest:

GSK Stockmann:

Stefan J. Schlapka (Lead, Real Estate), Stefan Dorn (Projects), Dirk Koch (Tax); Associates: Kerstin von Staa (Public), Dr. Mechtild-Maria Siebke (Real Estate/Finance), Tim Florian Metzmeier (Tax), Markus Werth (Tax), Karina Klein (Real Estate)

(photo: Everest Management GmbH)

Print


Press contact
Christine Ström
+49 30 203907-7763
presse@gsk.de

Back

GSK Updates
  • 23.12.2019

    GSK Update: Bill implementing ATAD 2 in Luxembourg domestic law and 2020 budget law voted on 19 December 2019

    Read more
  • 16.12.2019

    GSK Update: The state of play on the new German corporate sanctions law

    Read more
  • 20.09.2019

    GSK Update: GSK Update: Shareholders’ Rights Directive II: What is new for Luxembourg issuers?

    Read more
Contact person

Stefan J. Schlapka

Partner

+49 89 288174-75

stefan.schlapka@gsk.de